Hostname: page-component-5c6d5d7d68-wbk2r Total loading time: 0 Render date: 2024-08-27T22:09:26.989Z Has data issue: false hasContentIssue false
  • English
  • Français

Anxiety disorders and intravenous drug use in chemsex context

Published online by Cambridge University Press:  27 August 2024

J. Curto Ramos ,
A. Rodríguez Laguna ,
P. Barrio ,
L. Ibarguchi ,
A. García ,
I. Azqueta  and
H. Dolengevich Segal
J. Curto Ramos*
Affiliation:
1Department of Psychiatry, Clinical Psychology and Mental Health, La Paz University Hospital 2Apoyo Positivo
A. Rodríguez Laguna
Affiliation:
2Apoyo Positivo
P. Barrio
Affiliation:
2Apoyo Positivo
L. Ibarguchi
Affiliation:
2Apoyo Positivo
A. García
Affiliation:
2Apoyo Positivo
I. Azqueta
Affiliation:
2Apoyo Positivo
H. Dolengevich Segal
Affiliation:
3Dual Disorders Program. Department of Psychiatry, Henares University Hospital, Madrid, Spain
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Several studies have called atention to the mental health disorders associated with chemsex -the intentional use of drugs before or during sexual intercourse GBMSM (gay, bisexual and men who have sex with men) population-. Sexualized intravenous drug use is also known as slam or slamsex. There are few studies that analyze the mental health differences between intravenous drug users compared to non-intravenous drug users in chemsex context.

Objectives

We aim to describe the mental health outcomes including current and past anxiety disorders diagnosis in a sample of users with sexualized drug use (chemsex) attended by the non-governmental organization Apoyo Positivo in the program “Sex, Drugs and You” and to compare the differences of current and previous diagnosis of anxiety disorders between intravenous drug users compared to non-intravenous drug users.

Methods

A cross-sectional descriptive analysis of a sample of users attended by the non-governmental organization Apoyo Positivo in the program “Sex, Drugs and You” between 2016-2019 was performed.

Results

We included 217 participants. Current or past diagnosis of anxiety disorders was found in 142 participants. Anxiety disorders were significantly higher in the intravenous drug use group compared to the non-intravenous drug use group (p<0.05).

Conclusions

Previous studies have reported that MSM who practiced chemsex were more likely to experience from anxiety. In our study, anxiety disorders where higher in participantes who engaged in intravenous drug use. A multidisciplinary team is necessary to address chemsex and provide care and treatment for mental health problems such as anxiety, depression, suicidal behaviour or drug-induced psychosis.

Disclosure of Interest

None Declared

Type
Abstract
Information
European Psychiatry , Volume 67 , Special Issue S1: Abstracts of the 32nd European Congress of Psychiatry , April 2024 , pp. S354
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2024. Published by Cambridge University Press on behalf of European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.